100 related articles for article (PubMed ID: 31025537)
1. Estimation of CYP3A4*1B single nucleotide polymorphism in patients with recurrent Major Depressive Disorder.
Świechowski R; Jeleń A; Mirowski M; Talarowska M; Gałecki P; Pietrzak J; Wodziński D; Balcerczak E
Mol Genet Genomic Med; 2019 Jun; 7(6):e669. PubMed ID: 31025537
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.
Tsai MH; Lin KM; Hsiao MC; Shen WW; Lu ML; Tang HS; Fang CK; Wu CS; Lu SC; Liu SC; Chen CY; Liu YL
Pharmacogenomics; 2010 Apr; 11(4):537-46. PubMed ID: 20350136
[TBL] [Abstract][Full Text] [Related]
3. Relationship of
Parkhomenko AA; Zastrozhin MS; Skryabin V; Petukhov AE; Pozdniakov SA; Ivanchenko VA; Zaytsev IA; Bure IV; Bochkov PO; Akmalova KA; Smirnov VV; Bryun EA; Sychev DA
Psychopharmacol Bull; 2023 Dec; 53(4):8-14. PubMed ID: 38076668
[TBL] [Abstract][Full Text] [Related]
4. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
[TBL] [Abstract][Full Text] [Related]
5. CYP3A4*1B polymorphism and cancer risk: a HuGE review and meta-analysis.
Zhou LP; Yao F; Luan H; Wang YL; Dong XH; Zhou WW; Wang QH
Tumour Biol; 2013 Apr; 34(2):649-60. PubMed ID: 23179402
[TBL] [Abstract][Full Text] [Related]
6. The Influence of C3435T Polymorphism of the ABCB1 Gene on Genetic Susceptibility to Depression and Treatment Response in Polish Population - Preliminary Report.
Jeleń AM; Sałagacka A; Żebrowska MK; Mirowski M; Talarowska M; Gałecki P; Balcerczak EI
Int J Med Sci; 2015; 12(12):974-9. PubMed ID: 26664259
[TBL] [Abstract][Full Text] [Related]
7. Effect of Multidrug-Resistant 1 (MDR1) and CYP3A4*1B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients.
Kotowski MJ; Bogacz A; Bartkowiak-Wieczorek J; Tejchman K; Dziewanowski K; Ostrowski M; Czerny B; Grześkowiak E; Machaliński B; Sieńko J
Ann Transplant; 2019 Feb; 24():108-114. PubMed ID: 30799432
[TBL] [Abstract][Full Text] [Related]
8. The role of GRIK4 gene in treatment-resistant depression.
Milanesi E; Bonvicini C; Congiu C; Bortolomasi M; Gainelli G; Gennarelli M; Minelli A
Genet Res (Camb); 2015 Jul; 97():e14. PubMed ID: 26139080
[TBL] [Abstract][Full Text] [Related]
9. Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina.
Semiz S; Dujić T; Ostanek B; Prnjavorac B; Bego T; Malenica M; Mlinar B; Marc J; Causević A
Med Glas (Zenica); 2011 Feb; 8(1):84-9. PubMed ID: 21263403
[TBL] [Abstract][Full Text] [Related]
10. A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.
Zhang C; Li Z; Wu Z; Chen J; Wang Z; Peng D; Hong W; Yuan C; Wang Z; Yu S; Xu Y; Xu L; Xiao Z; Fang Y
Psychopharmacology (Berl); 2014 Feb; 231(4):685-93. PubMed ID: 24114429
[TBL] [Abstract][Full Text] [Related]
11. Unique CYP3A4 genetic variant in Brazilian tuberculosis patients with/without HIV.
Jeovanio-Silva AL; Monteiro TP; El-Jaick KB; do Brasil PE; Rolla VC; de Castro L
Mol Med Rep; 2012 Jan; 5(1):153-61. PubMed ID: 21964586
[TBL] [Abstract][Full Text] [Related]
12. CYP3A genotypes in Bangladeshi tuberculosis patients.
Maruf AA; Ahmed MU; Azad MA; Ahmed M; Hasnat A
Bangladesh Med Res Counc Bull; 2012 Apr; 38(1):1-5. PubMed ID: 22545342
[TBL] [Abstract][Full Text] [Related]
13. Impact of CYP3A4*1B and CYP3A5*3 polymorphisms on the pharmacokinetics of cyclosporine and sirolimus in renal transplant recipients.
Żochowska D; Wyzgał J; Pączek L
Ann Transplant; 2012; 17(3):36-44. PubMed ID: 23018254
[TBL] [Abstract][Full Text] [Related]
14. The influence of the CYP3A4*22 polymorphism on serum concentration of quetiapine in psychiatric patients.
van der Weide K; van der Weide J
J Clin Psychopharmacol; 2014 Apr; 34(2):256-60. PubMed ID: 24525658
[TBL] [Abstract][Full Text] [Related]
15. FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.
Santos M; Carvalho S; Lima L; Mota-Pereira J; Pimentel P; Maia D; Correia D; Gomes S; Cruz A; Medeiros R
J Affect Disord; 2015 Oct; 185():164-9. PubMed ID: 26186532
[TBL] [Abstract][Full Text] [Related]
16. Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy.
López-García MA; Feria-Romero IA; Serrano H; Rayo-Mares D; Fagiolino P; Vázquez M; Escamilla-Núñez C; Grijalva I; Escalante-Santiago D; Orozco-Suarez S
Pharmacol Rep; 2017 Jun; 69(3):504-511. PubMed ID: 28343093
[TBL] [Abstract][Full Text] [Related]
17. The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.
Bustos ML; Caritis SN; Jablonski KA; Reddy UM; Sorokin Y; Manuck T; Varner MW; Wapner RJ; Iams JD; Carpenter MW; Peaceman AM; Mercer BM; Sciscione A; Rouse DJ; Ramin SM;
Am J Obstet Gynecol; 2017 Sep; 217(3):369.e1-369.e9. PubMed ID: 28522317
[TBL] [Abstract][Full Text] [Related]
18. Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression.
Phillips JL; Batten LA; Tremblay P; Aldosary F; Du L; Blier P
Acta Neuropsychiatr; 2015 Dec; 27(6):353-61. PubMed ID: 25990886
[TBL] [Abstract][Full Text] [Related]
19. Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder.
Zastrozhin MS; Skryabin VY; Smirnov VV; Petukhov AE; Pankratenko EP; Zastrozhina AK; Grishina EA; Ryzhikova KA; Bure IV; Golovinskii PA; Koporov SG; Bryun EA; Sychev DA
Gene; 2020 May; 739():144513. PubMed ID: 32112986
[TBL] [Abstract][Full Text] [Related]
20. [Influence of CYP3A4/5 polymorphisms in the pharmacokinetics of levonorgestrel: a pilot study].
Moreno I; Quiñones L; Catalán J; Miranda C; Roco Á; Sasso J; Tamayo E; Cáceres D; Tchernitchin AN; Gaete L; Saavedra I
Biomedica; 2012; 32(4):570-7. PubMed ID: 23715232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
